Ozonized Low Density Lipoprotein (ozLDL) Inhibits NF-κB and IRAK-1–Associated Signaling
- 1 January 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 27 (1) , 226-232
Abstract
Objective— Recent studies have provided strong evidence for the presence of ozone in atherosclerotic lesions. In addition, modification of LDL has been suggested to be involved in atherosclerosis. ... Evidence suggests that ozone plays a role in atherosclerosis. We demonstrated that ozone-modified LDL (ozLDL) selectively and reversibly inhibited the NF-κB system, with an accompanying reduction i...Keywords
This publication has 26 references indexed in Scilit:
- A Role for Oxidized Phospholipids in AtherosclerosisNew England Journal of Medicine, 2005
- Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesisJournal of Lipid Research, 2005
- Detection of IKKβ-IKKγ Subcomplexes in Monocytic Cells and Characterization of Associated SignalingJournal of Biological Chemistry, 2004
- Evidence for Ozone Formation in Human Atherosclerotic ArteriesScience, 2003
- Evidence for Antibody-Catalyzed Ozone Formation in Bacterial Killing and InflammationScience, 2002
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- 4-Hydroxynonenal Prevents NF-κB Activation and Tumor Necrosis Factor Expression by Inhibiting IκB Phosphorylation and Subsequent ProteolysisJournal of Biological Chemistry, 1999
- Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate.Journal of Clinical Investigation, 1993
- Beyond CholesterolNew England Journal of Medicine, 1989
- Ozonization of cholesterolJournal of the American Chemical Society, 1983